found that siRNA-B7H3 downregulation led to decreased migration and invasion rates of FEMX-I melanoma (16% and 30%, respectively), decreased migration of FEMX-V melanoma cells (26%) and decreased migration and invasion rates of MA11 breast cancer cells (both 45%). Here, CD276 is linked to breast cancer.